Literature DB >> 28127029

Shared decision-making in HCM.

Barry J Maron1, Rick A Nishimura2, Martin S Maron1.   

Abstract

Mesh：

Year:  2017        PMID： 28127029     DOI： 10.1038/nrcardio.2017.6

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  Shared decision making--pinnacle of patient-centered care.

Authors:  Michael J Barry; Susan Edgman-Levitan
Journal:  N Engl J Med       Date:  2012-03-01       Impact factor: 91.245

2.  Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.

Authors:  Barry J Maron; James E Udelson; Robert O Bonow; Rick A Nishimura; Michael J Ackerman; N A Mark Estes; Leslie T Cooper; Mark S Link; Martin S Maron
Journal:  J Am Coll Cardiol       Date:  2015-11-02       Impact factor: 24.094

Review 3.  How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Genetic Disease With Low Mortality: Shaped by 50 Years of Clinical Research and Practice.

Authors:  Barry J Maron; Ethan J Rowin; Susan A Casey; Martin S Maron
Journal:  JAMA Cardiol       Date:  2016-04-01       Impact factor: 14.676

4.  Competitive athletes with cardiovascular disease--the case of Nicholas Knapp.

Authors:  B J Maron; M J Mitten; E F Quandt; D P Zipes
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245

5.  Implementation of shared decision making in cardiovascular care: past, present, and future.

Authors:  Erik P Hess; Megan Coylewright; Dominick L Frosch; Nilay D Shah
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-07-22

6.  Saving Lives One at a Time.

Authors:  Barry J Maron
Journal:  JAMA Cardiol       Date:  2016-07-01       Impact factor: 14.676

Review 7.  Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy.

Authors:  Barry J Maron; Martin S Maron
Journal:  Heart Rhythm       Date:  2016-01-01       Impact factor: 6.343

8.  2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

Authors:  Perry M Elliott; Aris Anastasakis; Michael A Borger; Martin Borggrefe; Franco Cecchi; Philippe Charron; Albert Alain Hagege; Antoine Lafont; Giuseppe Limongelli; Heiko Mahrholdt; William J McKenna; Jens Mogensen; Petros Nihoyannopoulos; Stefano Nistri; Petronella G Pieper; Burkert Pieske; Claudio Rapezzi; Frans H Rutten; Christoph Tillmanns; Hugh Watkins
Journal:  Eur Heart J       Date:  2014-08-29       Impact factor: 29.983

9.  Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.

Authors:  Barry J Maron; Paolo Spirito; Win-Kuang Shen; Tammy S Haas; Francesco Formisano; Mark S Link; Andrew E Epstein; Adrian K Almquist; James P Daubert; Thorsten Lawrenz; Giuseppe Boriani; N A Mark Estes; Stefano Favale; Marco Piccininno; Stephen L Winters; Massimo Santini; Sandro Betocchi; Fernando Arribas; Mark V Sherrid; Gianfranco Buja; Christopher Semsarian; Paolo Bruzzi
Journal:  JAMA       Date:  2007-07-25       Impact factor: 56.272

10.  Demographics and Epidemiology of Sudden Deaths in Young Competitive Athletes: From the United States National Registry.

Authors:  Barry J Maron; Tammy S Haas; Aneesha Ahluwalia; Caleb J Murphy; Ross F Garberich
Journal:  Am J Med       Date:  2016-04-01       Impact factor: 4.965
  10 in total
  2 in total

1.  Hypertrophic cardiomyopathy and exercise: a need for more information.

Authors:  Michael J Joyner
Journal:  J Physiol       Date:  2019-02-03       Impact factor: 5.182

2.  Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy.

Authors:  Martin S Maron; Ethan J Rowin; Benjamin S Wessler; Paula J Mooney; Amber Fatima; Parth Patel; Benjamin C Koethe; Mikhail Romashko; Mark S Link; Barry J Maron
Journal:  JAMA Cardiol       Date:  2019-07-01       Impact factor: 14.676
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.